https://pharmadog.xyz/news/404695 pharmadog en 2026-09-14T16:30:00.000Z AstraZeneca’s newly approved pill fails frontline breast cancer study https://pharmadog.xyz/news/404527 pharmadog en 2026-09-14T16:02:55.000Z Republicans push $500 cash checks for ACA enrollees, highlighting cash-first health policy and GLP-1 drug surge https://pharmadog.xyz/news/404463 pharmadog en 2026-09-14T15:57:28.000Z GSK to close German vaccine plant and cut 650 jobs as flu vaccine demand falls https://pharmadog.xyz/news/404567 pharmadog en 2026-09-14T15:46:00.000Z Cellectis abandons CAR-T programs, shifts focus to in vivo gene editing https://pharmadog.xyz/news/404507 pharmadog en 2026-09-14T15:25:49.000Z BioNTech's anti-CTLA-4 drug shows survival advantage in advanced squamous lung cancer at WCLC https://pharmadog.xyz/news/404464 pharmadog en 2026-09-14T15:21:55.000Z GSK reports 94% response rate for Jideytro in ROS1-positive lung cancer at World Conference https://pharmadog.xyz/news/404355 pharmadog en 2026-09-14T14:51:11.000Z Sanofi-backed Electra Therapeutics targets $297 million IPO as Enhertu shows Phase 3 lung cancer success https://pharmadog.xyz/news/404399 pharmadog en 2026-09-14T14:34:20.000Z Pennsylvania reports third measles death this year, a 40-year-old woman in Jefferson County https://pharmadog.xyz/news/404231 pharmadog en 2026-09-14T13:42:55.000Z Definium's LSD candidate DT120 shows positive Phase 3 results, moving toward FDA submission https://pharmadog.xyz/news/404251 pharmadog en 2026-09-14T13:34:37.000Z GSK presents promising late-stage lung cancer data from two investigational drugs https://pharmadog.xyz/news/404232 pharmadog en 2026-09-14T13:19:32.000Z Novo drops Nordisk from name, rebrands as Novo with new bull logo https://pharmadog.xyz/news/404084 pharmadog en 2026-09-14T13:07:51.000Z AstraZeneca's breast cancer drug camizestrant fails pivotal first-line trial https://pharmadog.xyz/news/404104 pharmadog en 2026-09-14T13:00:00.000Z FDA approves Scholar Rock's muscle-targeted SMA therapy Isembyld https://pharmadog.xyz/news/403995 pharmadog en 2026-09-14T12:47:07.000Z AstraZeneca’s Etcamah fails Phase 3 trial, dashing hopes for $2.9 billion breast cancer market https://pharmadog.xyz/news/404606 pharmadog en 2026-09-14T12:38:00.000Z Eli Lilly halts early-stage obesity drug LY4064912 after failing to meet development criteria https://pharmadog.xyz/news/403996 pharmadog en 2026-09-14T12:17:38.000Z Scholar Rock receives FDA approval for Isembyld, first muscle-targeted SMA therapy https://pharmadog.xyz/news/403803 pharmadog en 2026-09-14T11:54:13.000Z Novo Nordisk rebrands as 'Novo' and launches new culture strategy after recent setbacks https://pharmadog.xyz/news/403867 pharmadog en 2026-09-14T11:49:09.000Z Third measles-related death reported in Pennsylvania amid ongoing outbreak https://pharmadog.xyz/news/403804 pharmadog en 2026-09-14T11:29:31.000Z Scholar Rock receives FDA approval for apitegromab (Isembyld) to treat spinal muscular atrophy https://pharmadog.xyz/news/403805 pharmadog en 2026-09-14T11:21:38.000Z AstraZeneca's Etcamah fails late-stage trial for early-stage breast cancer use https://pharmadog.xyz/news/403695 pharmadog en 2026-09-14T11:00:08.000Z Definium Therapeutics reports positive Phase 3 results for oral LSD anxiety drug DT120 https://pharmadog.xyz/news/403739 pharmadog en 2026-09-14T11:00:00.000Z Definium’s LSD therapy cuts anxiety scores in second late-stage trial https://pharmadog.xyz/news/404330 pharmadog en 2026-09-14T10:07:00.000Z Corbus reports phase 1b obesity data showing lower neuropsychiatric side effects for CB1 antagonist https://pharmadog.xyz/news/403463 pharmadog en 2026-09-14T08:58:48.000Z Novo Nordisk rebrands as "Novo" to signal renewed focus amid slipping market share https://pharmadog.xyz/news/404331 pharmadog en 2026-09-14T08:55:00.000Z Electra Therapeutics targets up to $342M IPO to fund phase 2/3 study of ipsoprubart for rare inflammatory syndrome https://pharmadog.xyz/news/403465 pharmadog en 2026-09-14T08:30:00.000Z Opinion: Restoring public trust in science requires humility and collaboration, not just better messaging https://pharmadog.xyz/news/403464 pharmadog en 2026-09-14T08:30:00.000Z Football fan wrestles with love for the game amid rising CTE concerns https://pharmadog.xyz/news/403466 pharmadog en 2026-09-14T08:30:00.000Z Hospital leaders say GOP's $50 billion rural health fund falls far short of Medicaid cuts https://pharmadog.xyz/news/402803 pharmadog en 2026-09-14T07:00:00.000Z Cyclic peptide drugs gain traction as AI and hybrid synthesis aim to overcome manufacturing hurdles https://pharmadog.xyz/news/403779 pharmadog en 2026-09-14T06:55:00.000Z Novo rebrands, drops 'Nordisk' to become simply 'Novo' in market push https://pharmadog.xyz/news/403672 pharmadog en 2026-09-14T05:28:00.000Z Cellectis drops its allogeneic CAR-T candidates lasme-cel and eti-cel amid rising competition from in-vivo therapies https://pharmadog.xyz/news/403502 pharmadog en 2026-09-14T05:11:00.000Z Roche-MediLink’s B7-H3 ADC meets primary endpoint in phase 3 SCLC trial, median survival 13.3 months https://pharmadog.xyz/news/402804 pharmadog en 2026-09-14T05:00:00.000Z Sino Biological launches site-specific labeled proteins to aid cell surface research https://pharmadog.xyz/news/402805 pharmadog en 2026-09-14T04:20:00.000Z Public backing fuels FDA hearing on psychedelic therapies and potential COMP360 approval https://pharmadog.xyz/news/402655 pharmadog en 2026-09-14T04:01:00.000Z Merck and Moderna’s melanoma vaccine success spurs five rivals to chase personalized cancer vaccine breakthrough https://pharmadog.xyz/news/402656 pharmadog en 2026-09-14T04:00:00.000Z FDA approves Moderna’s mRNA flu vaccine as company reports positive Phase 3 cancer vaccine results https://pharmadog.xyz/news/401804 pharmadog en 2026-09-13T22:30:00.000Z Analysis says secret Trump pharma deals could cut projected Medicare savings from MFN pricing by up to 80% https://pharmadog.xyz/news/403946 pharmadog en 2026-09-13T11:53:00.000Z J&J nears $20 billion sale of DePuy Synthes orthopedics unit to Apollo https://pharmadog.xyz/news/400006 pharmadog en 2026-09-13T08:05:00.000Z GE HealthCare eyes $1 billion purchase of radiopharmaceutical developer Sofie Biosciences https://pharmadog.xyz/news/398267 pharmadog en 2026-09-13T01:46:49.000Z Akeso and Summit report survival advantage for PD-1xVEGF combo over Keytruda